Experts warn Ozempic and Mounjaro may cause sudden, irreversible blindness as patients report vision loss after taking the weight loss drugs.

Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.

Medical experts have raised concerns over popular weight loss drugs like Ozempic and Mounjaro after emerging evidence found ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

During the Super Bowl, Hims & Hers Health aired a commercial called “Sick of the System.” But before the 60-second spot was ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

A new study from Mass Eye and Ear suggests that people taking semaglutide, a drug sold as Ozempic and Wegovy, may have a ...

This study provides valuable insight into the increasing use of obesity drugs. The rising prescription numbers suggest that ...

Online sellers of knockoff GLP-1 drugs have seized on shortages as an opportunity to advertise a more steady, lower-cost supply of the products compared to branded versions. One such company, Hims & ...